Literature DB >> 11008738

The genetic basis of the osteochondrodysplasias.

A C Baitner1, S G Maurer, M B Gruen, P E Di Cesare.   

Abstract

The osteochondrodysplasias are a heterogeneous group of disorders characterized by abnormal growth and remodeling of cartilage and bone, affecting from 2 to 4.7 per 10,000 individuals. Most osteochondrodysplasias are heritable and many have elaborate patterns of genetic transmission. Affected individuals generally require management by multidisciplinary teams of specialists. In this review, we divide the osteochondrodysplasias into groups based on their genetic relationships, including mutations in various types of collagen, fibroblast growth factor, cartilage oligomeric matrix protein, parathyroid hormone receptor, the diastrophic dysplasia sulfate transporter, enzymes such as steroid sulfatases, transcription factor SOX9, and a cysteine proteinase, cathepsin K. We describe the major osteochondrodysplasias, define their causes and clinical manifestations, and provide the orthopaedic surgeon with an understanding of the underlying molecular defects as well as the anatomical aspects of these disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008738     DOI: 10.1097/00004694-200009000-00010

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  Histopathologic study of long-bone growth plates confirms the basset hound as an osteochondrodysplastic breed.

Authors:  Simón Martínez; Raúl Fajardo; Jesús Valdés; Raúl Ulloa-Arvizu; Rogelio Alonso
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

2.  Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum.

Authors:  Anne Pizard; Patrick G Burgon; David L Paul; Benoit G Bruneau; Christine E Seidman; J G Seidman
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  The impairment of MAGMAS function in human is responsible for a severe skeletal dysplasia.

Authors:  Cybel Mehawej; Agnès Delahodde; Laurence Legeai-Mallet; Valérie Delague; Nabil Kaci; Jean-Pierre Desvignes; Zoha Kibar; José-Mario Capo-Chichi; Eliane Chouery; Arnold Munnich; Valérie Cormier-Daire; André Mégarbané
Journal:  PLoS Genet       Date:  2014-05-01       Impact factor: 5.917

4.  A case of multivessel PTCA in achondroplasia patient.

Authors:  Viveka Kumar; Vivek Kumar
Journal:  Egypt Heart J       Date:  2016-03-15

5.  Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.

Authors:  Ricki S Carroll; Angela L Duker; Andrea J Schelhaas; Mary Ellen Little; Elissa G Miller; Michael B Bober
Journal:  Palliat Med Rep       Date:  2020-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.